2023/12/2 16:58:56
(AGN:CSE - AGNPF:OTCQB - AGN0:XFRA)
Newsletter coverage
Company News
Streetwise Reports Articles
9/6/2023 – Algernon Pharmaceuticals Announces Grant of U.S. Patent for Repirinast in NAFLD and NASH